Nobody buys an active ingredient from a shopping basket, and that is not the point.
Active ingredient commerce runs on catalogues, controlled documents and quotations — the machinery of ecommerce configured for a transaction that ends in a quality agreement, not a card payment.
Active ingredients are bought against specifications, quality agreements and long qualification cycles, at values and volumes that no card payment accommodates. Building a conventional storefront produces something nobody can use. What is genuinely needed is the rest of the ecommerce apparatus — a searchable catalogue, structured product data, a basket, an account, an enquiry that carries context — configured so the final step is a formal quotation and a document exchange. That is a straightforward reconfiguration and a very different brief from a retail build.
A formulation scientist searches by international non-proprietary name, by CAS number, sometimes by a synonym or a former name, and filters by pharmacopoeial standard, polymorphic form, particle size or grade. Category browsing is close to useless here. Investing in a forgiving substance search that tolerates alternative nomenclature, and in filters that match how a specification is written, is where the usability of an active ingredient catalogue is decided — and it is what turns a product list into something a technical buyer will return to.
What a customer actually wants from the site is a specification sheet, a certificate of analysis, a safety data sheet, the open part of a drug master file, a sample, or a quality agreement — each with a different level of formality and some requiring an agreement first. Building this as a considered request flow, with clear indication of what is available immediately and what needs a signature, converts far better than a contact form and gives your commercial team a qualified request with context rather than a name and a sentence.
Filing status differs by market: a drug master file in one region, a certificate of suitability in another, a pending submission in a third, nothing at all elsewhere. Presenting a single global status misleads a buyer whose entire question is whether they can use the ingredient in their filing. Holding status per region as an attribute of the substance, and showing it plainly, answers that question at the moment it is asked and removes a round of correspondence that currently occupies your regulatory affairs team.
Sample requests involve quantity limits, controlled substance considerations, export documentation, shipping restrictions and often a confidentiality agreement — and they are one of the strongest buying signals you receive. Treating a sample request as a routine order produces compliance problems; treating it as a plain email loses the context. Building it as a structured request that captures the intended use, the market and the quantity, and routes to the right internal approval, both protects the process and gives your team a genuinely qualified lead.
Specifications change, filings progress, grades are added and products discontinued. A catalogue maintained by hand diverges from the regulatory reality quickly, and a specification that does not match the current documentation is worse than no catalogue at all — it introduces a discrepancy into a customer’s evaluation. Generating product pages from the same records your regulatory affairs team maintains means the site is correct because it is derived from the source, and a new certificate updates the catalogue as a consequence of the regulatory work.
What comes up when building a commercial catalogue for active ingredients.
Direct online purchase, rarely. The underlying machinery, very much so. What buyers need is to find a substance, verify its specification and filing status, assemble a request and receive a formal quotation with the documentation their process requires. That is ecommerce with a different final step. Where it does extend to ordering is with established customers on agreed terms, effectively a reordering portal rather than a shop.
Specifications, safety data sheets, pharmacopoeial reference and filing status generally can be, along with the open part of a drug master file, which is intended to be shareable. Restricted sections and detailed process information stay behind an agreement. Suppliers most often lose enquiries by gating everything, including material available from public registers, which signals difficulty before a relationship exists. Making the open material genuinely accessible is both safe and commercially effective.
Yes, as a structured request rather than as a basket item. Samples carry quantity limits, export and controlled substance considerations and often an agreement, so they need routing and approval rather than automatic fulfilment. Capturing the intended use, market and quantity in a proper form gives your team a genuinely qualified lead and ensures the compliance checks happen. What should be avoided is both extremes — an unrestricted add to basket, and a generic contact form that loses all the context.
It is, because the catalogue is how you reach the projects you are not currently invited to. Formulation teams routinely search for second sources and for substances outside their existing supplier’s range, and that search is on the molecule. Your established customers will keep buying as they always have; the catalogue exists for the evaluation happening elsewhere, which today is happening without you in it.
A PDF product list that no formulator can search, specifications that no longer match the current filing, and sample requests arriving as unstructured emails. Tell us how many substances you supply and we will tell you what a technical buyer can find today.